Advisor Group Holdings, Inc. Ptc Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 110 shares of PTCT stock, worth $5,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110

Previous 137 19.71%

Holding current value

$5,575

Previous $5,000 20.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$34.99 - $52.07 $944 - $1,405	-27 Reduced 19.71%	110 $4,000
Q3 2024 Nov 13, 2024	SELL	$30.39 - $37.66 $60 - $75	-2 Reduced 1.44%	137 $5,000
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $1,333 - $2,166	54 Added 63.53%	139 $4,000
Q1 2024 May 10, 2024	SELL	$24.15 - $31.95 $5,602 - $7,412	-232 Reduced 73.19%	85 $2,000
Q4 2023 Feb 12, 2024	BUY	$18.07 - $29.37 $1,463 - $2,378	81 Added 34.32%	317 $8,000
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $4,168 - $7,810	-186 Reduced 44.08%	236 $5,000
Q2 2023 Aug 10, 2023	SELL	$40.4 - $59.1 $5,454 - $7,978	-135 Reduced 24.24%	422 $17,000
Q1 2023 May 12, 2023	BUY	$38.16 - $48.86 $7,517 - $9,625	197 Added 54.72%	557 $26,000
Q4 2022 Feb 10, 2023	SELL	$33.53 - $54.79 $3,319 - $5,424	-99 Reduced 21.57%	360 $13,000
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $5,314 - $6,838	-127 Reduced 21.67%	459 $23,000
Q2 2022 Aug 10, 2022	SELL	$25.6 - $45.23 $6,272 - $11,081	-245 Reduced 29.48%	586 $23,000
Q1 2022 May 04, 2022	BUY	$33.33 - $44.6 $7,799 - $10,436	234 Added 39.2%	831 $31,000
Q3 2021 Nov 05, 2021	BUY	$37.01 - $44.74 $2,627 - $3,176	71 Added 13.5%	597 $22,000
Q2 2021 Aug 02, 2021	SELL	$37.95 - $49.37 $5,047 - $6,566	-133 Reduced 20.18%	526 $22,000
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $702 - $1,033	-15 Reduced 2.23%	659 $32,000
Q4 2020 Feb 10, 2021	SELL	$47.96 - $67.64 $24,651 - $34,766	-514 Reduced 43.27%	674 $41,000
Q3 2020 Nov 12, 2020	SELL	$45.41 - $57.07 $1,907 - $2,396	-42 Reduced 3.41%	1,188 $55,000
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $3,787 - $4,893	89 Added 7.8%	1,230 $62,000
Q1 2020 May 18, 2020	BUY	$32.37 - $59.36 $36,934 - $67,729	1,141 New	1,141 $51,000

Others Institutions Holding PTCT

# of Institutions

257

Shares Held

77.3M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.63B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ptc Therapeutics, Inc. Transaction History